We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novartis To Topple Teva As World's Largest Generics Maker

Law360 (February 21, 2005, 12:00 AM EST) -- Swiss drug maker Novartis’ acquisition of Hexal in Germany and Eon Labs in the U.S. for a total of more than $8 billion will create the world’s largest generics drug maker,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.